Contact this trialFirst, we need to learn more about you.
mTOR Inhibitor
Drug Combination for Advanced Cancer
Recruiting3 awardsPhase 1
Houston, Texas
This trial is investigating a combination of drugs to treat advanced cancer, and the safety of the drug combination. Up to 249 patients will take part at MD Anderson.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service